Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Jump to navigation Jump to search

WikiDoc Resources for Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Articles

Most recent articles on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Most cited articles on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Review articles on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Articles on Pyogenic sterile arthritis, pyoderma gangrenosum, acne in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Images of Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Photos of Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Podcasts & MP3s on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Videos on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Evidence Based Medicine

Cochrane Collaboration on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Bandolier on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

TRIP on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Clinical Trials

Ongoing Trials on Pyogenic sterile arthritis, pyoderma gangrenosum, acne at Clinical Trials.gov

Trial results on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Clinical Trials on Pyogenic sterile arthritis, pyoderma gangrenosum, acne at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

NICE Guidance on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

NHS PRODIGY Guidance

FDA on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

CDC on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Books

Books on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

News

Pyogenic sterile arthritis, pyoderma gangrenosum, acne in the news

Be alerted to news on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

News trends on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Commentary

Blogs on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Definitions

Definitions of Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Patient Resources / Community

Patient resources on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Discussion groups on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Patient Handouts on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Directions to Hospitals Treating Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Risk calculators and risk factors for Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Healthcare Provider Resources

Symptoms of Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Causes & Risk Factors for Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Diagnostic studies for Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Treatment of Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Continuing Medical Education (CME)

CME Programs on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

International

Pyogenic sterile arthritis, pyoderma gangrenosum, acne en Espanol

Pyogenic sterile arthritis, pyoderma gangrenosum, acne en Francais

Business

Pyogenic sterile arthritis, pyoderma gangrenosum, acne in the Marketplace

Patents on Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Experimental / Informatics

List of terms related to Pyogenic sterile arthritis, pyoderma gangrenosum, acne

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Synonyms and keywords:

Overview

Historical Perspective

  • Papa syndrome was first discovered by Dr. Noralane M. Lindor, in 1997 following visiting several patients from three generations of a family with similar presentations.[1]
  • The association between PSTPIP1 gene mutation and Papa syndrome was made in the year 2000.[2]

Classification

  • There is no established system for the classification of Papa syndrome.

Pathophysiology

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].

OR

[Pathogen name] is usually transmitted via the [transmission route] route to the human host.

OR

Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.

OR


[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].

OR

The progression to [disease name] usually involves the [molecular pathway].

OR

The pathophysiology of [disease/malignancy] depends on the histological subtype.

Causes

Papa syndrome is caused by a mutation in the PSTPIP1 gene.[2]

Differentiating ((Page name)) from Other Diseases

  • Papa syndrome must be differentiated from other diseases that cause arthritis , skin rash, and pyoderma gangeronosum, such as [differential dx1], [differential dx2], and [differential dx3].

Epidemiology and Demographics

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.

OR

In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

OR

In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.


Patients of all age groups may develop [disease name].

OR

The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.

OR

[Disease name] commonly affects individuals younger than/older than [number of years] years of age.

OR

[Chronic disease name] is usually first diagnosed among [age group].

OR

[Acute disease name] commonly affects [age group].

  • There is no racial predilection to Papa syndrome.
  • Papa syndrome affects men and women equally.
  • The majority of Papa syndrome cases are reported in Europe, New Zealand, and the USA.

Risk Factors

  • There are no established risk factors for Papa syndrome.

Screening

  • There is insufficient evidence to recommend routine screening for Papa syndrome.

Natural History, Complications, and Prognosis

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

OR

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

OR

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

Diagnosis

Diagnostic Study of Choice

  • There are no established criteria for the diagnosis of Papa syndrome. The diagnosis may be made clinically.
  • Genetic analysis and location of a mutation in the PSTPIP1 gene may be done for the confirmation of the diagnosis. However, there are reported cases of Papa syndrome with negative genetic results.

History and Symptoms

  • A positive history of recurrent arthritis, skin ulceration, and acne is suggestive of Papa syndrome.
  • The presenting symptom of Papa syndrome is usually culture-negative arthritis.

Physical Examination

  • Physical examination of patients with Papa syndrome is usually remarkable for arthritis, cystic acne, and pyoderma gangeronosum.

Laboratory Findings

  • Laboratory findings consistent with the diagnosis of Papa syndrome include elevated serum levels of C-reactive protein (CRP), Erythrocyte sedimentation rate (ESR), and WBC.

Electrocardiogram

  • There are no ECG findings associated with Papa syndrome.

X-ray

There are no x-ray findings associated with [disease name].

OR

An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Echocardiography or Ultrasound

There are no echocardiography/ultrasound findings associated with [disease name].

OR

Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

CT scan

There are no CT scan findings associated with [disease name].

OR

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

MRI

There are no MRI findings associated with [disease name].

OR

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Other Imaging Findings

  • There are no other imaging findings associated with Papa syndrome.

Other Diagnostic Studies

  • There are no other diagnostic studies associated with Papa syndrome.

Treatment

Medical Therapy

  • There is no treatment for Papa syndrome; the mainstay of therapy is supportive care.

Surgery

  • Surgical intervention is not recommended for the management of Papa syndrome.

Primary Prevention

  • There are no established measures for the primary prevention of Papa syndrome.

Secondary Prevention

  • There are no established measures for the secondary prevention of Papa syndrome.

References

  1. Lindor, Noralane M.; Arsenault, Todd M.; Solomon, Herman; Seidman, Christine E.; McEvoy, Marian T. (1997). "A New Autosomal Dominant Disorder of Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, and Acne: PAPA Syndrome". Mayo Clinic Proceedings. 72 (7): 611–615. doi:10.4065/72.7.611. ISSN 0025-6196.
  2. 2.0 2.1 Yeon, Howard B.; Lindor, Noralane M.; Seidman, J.G.; Seidman, Christine E. (2000). "Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome Maps to Chromosome 15q". The American Journal of Human Genetics. 66 (4): 1443–1448. doi:10.1086/302866. ISSN 0002-9297.


Template:WikiDoc Sources